CN101524468A - Medicine for treating AIDS - Google Patents

Medicine for treating AIDS Download PDF

Info

Publication number
CN101524468A
CN101524468A CN200910119092A CN200910119092A CN101524468A CN 101524468 A CN101524468 A CN 101524468A CN 200910119092 A CN200910119092 A CN 200910119092A CN 200910119092 A CN200910119092 A CN 200910119092A CN 101524468 A CN101524468 A CN 101524468A
Authority
CN
China
Prior art keywords
radix
medicine
aids
rhizoma
isatidis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200910119092A
Other languages
Chinese (zh)
Inventor
李卓伦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN200910119092A priority Critical patent/CN101524468A/en
Publication of CN101524468A publication Critical patent/CN101524468A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a medicine 'Aierkang' for treating AIDS. The medicine is a pure traditional Chinese medicine preparation with a recipe and two dosage forms prepared from traditional Chinese medicine decoction pieces of ginseng, hairy deerhorn, linearstripe rabdosia herb, natural indigo notoginseng and the like. The medicine has efficacies of regulating qi and blood, reinforcing the primordial qi, clearing away heat and toxic materials, absorbing clots and promoting tissue regeneration, effectively killing AIDS virus and promoting immunocytes regeneration, and can significantly improve clinical symptoms of patients until the AIDS is cured. The medicine 'Aierkang' for treating AIDS has the clinical effective rate up to 95% and the clinical cure rate up to 21%, and is a relatively perfect medicine for treating AIDS.

Description

The medicine of treatment acquired immune deficiency syndrome (AIDS)
The present invention relates to a kind of medicine for the treatment of acquired immune deficiency syndrome (AIDS).Specifically being exactly with the prepared slices of Chinese crude drugs is the Chinese patent medicine preparation " Ai Erkang " of the special for treating acquired immune deficiency syndrome (AIDS) that forms of feed purification.
Acquired immune deficiency syndrome (AIDS), has just been stretched in the whole world since the U.S. finds with surprising rapidity from early eighties, and serious prestige is being assisted human beings'health existence.At the higher South Africa Region of sickness rate, the HIV infection rate is up to 20%-50%, and the AIDS sickness rate is up to 15%-20%.The HIV sufferers of China also surpasses 1,000,000.This new serious prestige of lethal infectious disease is being assisted human beings'health existence.
The object of the present invention is to provide and a kind ofly can effectively kill HIV virus, promote immunocyte regeneration, the AIDS conditions of patients is taken a turn for the better rapidly and reach the new medicine preparation of the target of healing.
Solution of the present invention is in China, Southeast Asia, ground such as Southern Africa have carried out the epidemiology investigation to this disease, this sick pathogeny has been carried out further investigation and has done to filter out on the basis of a large amount of clinical trials to have benefiting qi and nourishing blood with theory of Chinese medical science, heat-clearing and toxic substances removing, can effectively kill HIV virus, promote the prepared slices of Chinese crude drugs of multiple efficacies such as cd4 cell regeneration, be prepared from pill or injection formulation with conventional method, make its performance QI and blood regulating, tonifying vital QI, heat-clearing and toxic substances removing, blood stasis dispersing and fresh blood promoting, antiviral, improve the effect of immunologic function, to reach the purpose of effective treatment acquired immune deficiency syndrome (AIDS).
Medicine of the present invention is made by following component:
Radix Ginseng 50g-100g 50g-100g Radix Ophiopogonis Cornu Cervi Pantotrichum 50g-100g Herba Rabdosiae Lophanthoidis 60g-90g
Radix Scutellariae 20g-50g Calculus Bovis 10g-30g Indigo Naturalis 20g-40g Flos Lonicerae 30g-120g
Cinnabaris 10g-20g Realgar 10g-20g Radix Notoginseng 30g-60g Mentholum 10g-30g
Rhizoma Coptidis 20g-50g Radix Salviae Miltiorrhizae 20g-50g Rhizoma Atractylodis Macrocephalae 10g-30g Herba Hedyotidis Diffusae 50g-90g
Radix Bupleuri 10g-30g Cortex Moutan 20g-60g Rhizoma Dioscoreae 20g-60g Folium Isatidis 10g-30g
Moschus 10g-20g Radix Rehmanniae 60g-90g Radix Rehmanniae Preparata 60g-90g Radix Isatidis 20g-60g
The formula optimization weight proportion scope of preparation medicine of the present invention is:
Radix Ginseng 80g-100g 80g-100g Radix Ophiopogonis Cornu Cervi Pantotrichum 50g-80g Herba Rabdosiae Lophanthoidis 80g-90g
Radix Scutellariae 20g-30g Calculus Bovis 10g-20g Indigo Naturalis 20g-30g Flos Lonicerae 60g-80g
Cinnabaris 10g-20g Realgar 10g-20g Radix Notoginseng 30g-50g Mentholum 10g-30g
Rhizoma Coptidis 20g-30g Radix Salviae Miltiorrhizae 30g-50g Rhizoma Atractylodis Macrocephalae 20g-30g Herba Hedyotidis Diffusae 60g-80g
Radix Bupleuri 20g-30g Cortex Moutan 30g-50g Rhizoma Dioscoreae 30g-50g Folium Isatidis 20g-30g
Moschus 10g-20g Radix Rehmanniae 60g-70g Radix Rehmanniae Preparata 60g-70g Radix Isatidis 30g-50g
The optimum weight proportioning of preparation medicine of the present invention is:
Radix Ginseng 80g 80g Radix Ophiopogonis Cornu Cervi Pantotrichum 60g Herba Rabdosiae Lophanthoidis 90g
Radix Scutellariae 30g Calculus Bovis 10g Indigo Naturalis 25g Flos Lonicerae 80g
Cinnabaris 10g Realgar 15g Radix Notoginseng 35g Mentholum 15g
Rhizoma Coptidis 25g Radix Salviae Miltiorrhizae 35g Rhizoma Atractylodis Macrocephalae 30g Herba Hedyotidis Diffusae 80g
Radix Bupleuri 25g Cortex Moutan 30g Rhizoma Dioscoreae 45g Folium Isatidis 30g
Moschus 10g Radix Rehmanniae 65g Radix Rehmanniae Preparata 65g Radix Isatidis 50g
Above-mentioned each component medicine both can have been made medicine " Ai Erkang " ball and " Ai Erkang " injection that the present invention treats acquired immune deficiency syndrome (AIDS) according to a conventional method.
The present invention treats through being used for of developing of the clinical practice surplus in the of 30 year on the basis of " immunologic balance therapy " of immune dysfunction at me, in China, Southeast Asia and Southern Africa acquired immune deficiency syndrome (AIDS) has been carried out comprehensive on-the-spot investigation, with the theory of Chinese medical science is guidance, through a large amount of clinical trials, constantly improve to form.Its characteristics are that it is the pure natural medical preparation, determined curative effect, no obvious toxic-side effects.
Based on this medicine, the medicine of partner treatment opportunistic infection, treating both the principal and the secondary aspects of a disease at the same time, reinforcement and elimination in combination can make the rapid deactivation of HIV (human immunodeficiency virus), makes ruined immunocyte regeneration, and patient's clinical symptoms is improved until healing.Effective percentage is more than 95%.Clinical cure rate 21%.It is a kind of medicine of comparatively ideal treatment acquired immune deficiency syndrome (AIDS).

Claims (3)

1. medicine for the treatment of acquired immune deficiency syndrome (AIDS), its characteristic are that his active ingredient made by following materials of weight proportions.
Radix Ginseng 50g-100g 50g-100g Radix Ophiopogonis Cornu Cervi Pantotrichum 50g-100g Herba Rabdosiae Lophanthoidis 60g-90g
Radix Scutellariae 20g-50g Calculus Bovis 10g-30g Indigo Naturalis 20g-40g Flos Lonicerae 30g-120g
Cinnabaris 10g-20g Realgar 10g-20g Radix Notoginseng 30g-60g Mentholum 10g-30g
Rhizoma Coptidis 20g-50g Radix Salviae Miltiorrhizae 20g-50g Rhizoma Atractylodis Macrocephalae 10g-30g Herba Hedyotidis Diffusae 50g-90g
Radix Bupleuri 10g-30g Cortex Moutan 20g-60g Rhizoma Dioscoreae 20g-60g Folium Isatidis 10g-30g
Moschus 10g-20g Radix Rehmanniae 60g-90g Radix Rehmanniae Preparata 60g-90g Radix Isatidis 20g-60g
2. the medicine of the described treatment acquired immune deficiency syndrome (AIDS) of claim 1, its characteristic are that its active ingredient made by following materials of weight proportions.
Radix Ginseng 80g-100g 80g-100g Radix Ophiopogonis Cornu Cervi Pantotrichum 50g-80g Herba Rabdosiae Lophanthoidis 80g-90g
Radix Scutellariae 20g-30g Calculus Bovis 10g-20g Indigo Naturalis 20g-30g Flos Lonicerae 60g-80g
Cinnabaris 10g-20g Realgar 10g-20g Radix Notoginseng 30g-50g Mentholum 10g-30g
Rhizoma Coptidis 20g-30g Radix Salviae Miltiorrhizae 30g-50g Rhizoma Atractylodis Macrocephalae 20g-30g Herba Hedyotidis Diffusae 60g-80g
Radix Bupleuri 20g-30g Cortex Moutan 30g-50g Rhizoma Dioscoreae 30g-50g Folium Isatidis 20g-30g
Moschus 10g-20g Radix Rehmanniae 60g-70g Radix Rehmanniae Preparata 60g-70g Radix Isatidis 30g-50g
3. the medicine of the described treatment acquired immune deficiency syndrome (AIDS) of claim 1, its characteristic are that its active ingredient made by following materials of weight proportions.
Radix Ginseng 80g 80g Radix Ophiopogonis Cornu Cervi Pantotrichum 60g Herba Rabdosiae Lophanthoidis 90g
Radix Scutellariae 30g Calculus Bovis 10g Indigo Naturalis 25g Flos Lonicerae 80g
Cinnabaris 10g Realgar 15g Radix Notoginseng 35g Mentholum 15g
Rhizoma Coptidis 25g Radix Salviae Miltiorrhizae 35g Rhizoma Atractylodis Macrocephalae 30g Herba Hedyotidis Diffusae 80g
Radix Bupleuri 25g Cortex Moutan 30g Rhizoma Dioscoreae 45g Folium Isatidis 30g
Moschus 10g Radix Rehmanniae 65g Radix Rehmanniae Preparata 65g Radix Isatidis 50g
CN200910119092A 2009-03-23 2009-03-23 Medicine for treating AIDS Pending CN101524468A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN200910119092A CN101524468A (en) 2009-03-23 2009-03-23 Medicine for treating AIDS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN200910119092A CN101524468A (en) 2009-03-23 2009-03-23 Medicine for treating AIDS

Publications (1)

Publication Number Publication Date
CN101524468A true CN101524468A (en) 2009-09-09

Family

ID=41092643

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200910119092A Pending CN101524468A (en) 2009-03-23 2009-03-23 Medicine for treating AIDS

Country Status (1)

Country Link
CN (1) CN101524468A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104208250A (en) * 2014-09-23 2014-12-17 李绍华 Pharmaceutical composition for treating acquired immune deficiency syndrome (AIDS)
CN109010592A (en) * 2018-07-31 2018-12-18 赵金朋 A kind for the treatment of Traditional Chinese medicine liniment of AIDS and preparation method thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104208250A (en) * 2014-09-23 2014-12-17 李绍华 Pharmaceutical composition for treating acquired immune deficiency syndrome (AIDS)
CN109010592A (en) * 2018-07-31 2018-12-18 赵金朋 A kind for the treatment of Traditional Chinese medicine liniment of AIDS and preparation method thereof

Similar Documents

Publication Publication Date Title
CN101129817B (en) Chinese medicine formulation for treating hypertension and method of producing the same
CN100534513C (en) Chinese medicinal ointment for treating bones and tendons injury pain
CN104398982A (en) Traditional Chinese medicine composition for treating traumatic injury and joint pain and swelling
CN102580041A (en) Chinese medicinal decoction for preventing and treating thromboangiitis obliterans
CN104606582A (en) Traditional Chinese medicine formula for treating anemofrigid-damp arthralgia
CN102247497A (en) Chinese patent medicine for treating rheumatoid arthritis
CN104288388A (en) Medicament for treating acute inflammatory demyelinating polyneuropathies and preparation method of medicament
CN106177819A (en) A kind of external medicine composition for cervical spondylosis, preparation method and applications
CN101524468A (en) Medicine for treating AIDS
CN102218132B (en) Medicinal composition for treating nasal bleeding
CN103611100A (en) Traditional Chinese medicine for treating toothaches
CN103845675A (en) Traditional Chinese medicine ointment for treating osteoarthrosis
CN1076619C (en) Moxiburning medicine for acupoint therapy
CN101721479A (en) Chinese herbal medicine preparation for treating rheumatalgia
CN1298724A (en) Medicine for treating immunodefiiciency disease
CN102526685A (en) Medicament for treating cervical spondylosis
CN102406753B (en) Chinese medicinal composition for treating Bi syndrome
CN107233433A (en) Tinea pedis dissipates, preparation method and applications and herbal medicine immersion agent and preparation method thereof
CN101658661A (en) Chinese medicinal composition having effect of promoting blood circulation and removing blood stasis
CN104826043A (en) Chinese medicinal formula for treating crural sprain
CN104415293A (en) Foot-bath powder and method for preparing same
CN105616559A (en) Composition for treating acute bacillary dysentery
CN1342481A (en) Medicine for treating AIDS
CN103690748B (en) A kind of deep essence of the Radix Euphorbiae Fischerianae (Radix Euphorbiae Ebracteolatae) for the treatment of hyperosteogeny
CN103705901A (en) Traditional Chinese medicine composition for treating necrospermia

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20090909